"Data should simply be a measure of a broader organizational objective," one expert explained. "When the data becomes the goal, that's where organizations can get into trouble."

Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.

The updated labeling comes after the devices were found to be both safe and effective for the treatment of ruptured aneurysms. 

Today's sophisticated mapping systems allow clinicians to visualize VT circuits with unprecedented detail.

The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.

The daily polypill was also associated with improved drug adherence, according to new research out of UT Southwestern.

Patients were randomized to undergo treatment with the new-look AnchorMan or the Watchman 2.5. A follow-up study comparing the AnchorMan to the Watchman FLX and FLX Pro devices is already planned.

This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.

Current research suggests this technology is just getting started when it comes to transforming patient care.

Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 

“Optimizing BCS within the LCS population may have the potential to reduce screening disparities and increase early breast cancer detection," researchers write in JACR. 

The phenomenon is not unique to healthcare, but researchers have been exploring the prevalence and predictability of these experiences in medical settings.